John C Gore Selected Research

C.I. direct red 80

10/2022	Multiparametric magnetic resonance imaging in diagnosis of long-term renal atrophy and fibrosis after ischemia reperfusion induced acute kidney injury in mice.
11/2019	Noninvasive quantitative magnetization transfer MRI reveals tubulointerstitial fibrosis in murine kidney.
12/2018	Assessment of renal fibrosis in murine diabetic nephropathy using quantitative magnetization transfer MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John C Gore Research Topics

Disease

50	Neoplasms (Cancer) 12/2022 - 04/2006
9	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2007
9	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2008
7	Fibrosis (Cirrhosis) 10/2022 - 11/2007
6	Brain Neoplasms (Brain Tumor) 10/2020 - 09/2012
5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2013
5	Colonic Neoplasms (Colon Cancer) 01/2020 - 10/2012
4	Glioma (Gliomas) 04/2019 - 04/2011
3	Ischemic Stroke 01/2018 - 04/2011
3	Stroke (Strokes) 10/2016 - 09/2012
2	Acute Erythroblastic Leukemia (Erythroleukemia) 12/2022 - 01/2017
2	Kidney Diseases (Kidney Disease) 01/2021 - 04/2014
2	Infections 01/2018 - 06/2012
2	Insulin Resistance 06/2017 - 06/2015
2	Polyploidy 04/2017 - 01/2012
2	Pain (Aches) 01/2017 - 05/2016
2	Polyps 01/2017 - 09/2008
2	Calcinosis 03/2015 - 07/2014
2	Amyloid Plaque 01/2015 - 01/2013
2	Inflammation (Inflammations) 07/2014 - 01/2009
2	Liver Diseases (Liver Disease) 11/2008 - 09/2006
2	Hypoglycemia (Reactive Hypoglycemia) 02/2007 - 07/2006
1	Atrophy 10/2022
1	Schizophrenia (Dementia Praecox) 11/2021
1	Acute Kidney Injury (Acute Renal Failure) 07/2021
1	Pathologic Processes 10/2020
1	Contusions 01/2020
1	Cognitive Dysfunction 01/2020
1	Relapsing-Remitting Multiple Sclerosis 01/2020
1	Chronic Renal Insufficiency 11/2019
1	Necrosis 04/2019
1	Ischemia 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Leukemia 02/2017
1	Myeloid Leukemia (Leukemia, Myelocytic) 05/2016

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 07/2021 - 11/2008
9	APTIBA 01/2018 - 09/2011
8	AmidesIBA 01/2021 - 09/2011
8	Protons (Proton)IBA 11/2019 - 09/2011
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2011
5	AntigensIBA 03/2015 - 05/2009
4	SaponinsIBA 12/2022 - 05/2016
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 07/2006
4	Peanut AgglutininIBA 01/2017 - 11/2011
4	Thomsen-Friedenreich antigenIBA 01/2017 - 11/2011
4	Contrast MediaIBA 09/2012 - 11/2006
3	C.I. direct red 80IBA 10/2022 - 12/2018
3	Biological ProductsIBA 01/2021 - 04/2011
3	CollagenIBA 01/2021 - 12/2018
3	Amyloid (Amyloid Fibrils)IBA 01/2019 - 01/2013
3	poly(N-vinylacetamide)IBA 07/2015 - 11/2011
2	Cetuximab (Erbitux)FDA Link 01/2019 - 11/2008
2	SodiumIBA 10/2017 - 06/2017
2	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 04/2017 - 01/2012
2	AerosolsIBA 01/2017 - 01/2015
2	Analgesics (Analgesic Drugs)IBA 01/2017 - 05/2016
2	CurcuminIBA 01/2017 - 01/2015
2	Pharmaceutical PreparationsIBA 01/2016 - 03/2011
2	Polystyrenes (Polystyrene)IBA 07/2015 - 03/2015
2	Blood Glucose (Blood Sugar)IBA 06/2015 - 07/2006
2	SugarsIBA 03/2015 - 11/2011
2	CalciumIBA 03/2015 - 07/2014
2	coumarin 6IBA 03/2015 - 03/2011
2	azuleneIBA 01/2012 - 01/2009
2	alovudineIBA 07/2009 - 11/2008
2	Caspase 3 (Caspase-3)IBA 07/2009 - 11/2008
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2009 - 11/2007
2	ManganeseIBA 11/2008 - 05/2008
1	ParaffinIBA 10/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2020
1	LigandsIBA 01/2020
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	antineoplaston A10 (A 10)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Coloring Agents (Dyes)IBA 12/2018
1	Iohexol (Omnipaque)FDA Link 01/2018
1	CholesterolIBA 01/2016
1	tyramine-deoxysorbitolIBA 01/2016
1	130-nm albumin-bound paclitaxelIBA 01/2016
1	Antimitotic AgentsIBA 01/2016
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Cardiac GlycosidesIBA 01/2016
1	Cardiotonic Agents (Cardiac Stimulants)IBA 01/2016
1	Gadolinium DTPA (Magnevist)FDA Link 12/2015
1	coumarinIBA 07/2015

Therapy/Procedure

16	Therapeutics 01/2020 - 01/2009
5	Neoadjuvant Therapy 01/2020 - 01/2007
5	Drug Therapy (Chemotherapy) 03/2015 - 01/2007
4	Nanospheres 07/2015 - 03/2011
2	Injections 12/2015 - 11/2007
2	Lasers (Laser) 04/2014 - 06/2012
2	Parenteral Nutrition 11/2008 - 09/2006
1	Immunotherapy 01/2020
1	Radiotherapy 04/2019
1	Intravenous Injections 01/2018
1	Renal Dialysis (Hemodialysis) 06/2017